Heidelberg Pharma AG

Declaration of Voting Results & Voting Rights Announcements • Mar 7, 2022

News Details

Voting Rights Announcements | 7 March 2022 13:57

Heidelberg Pharma AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Heidelberg Pharma AG

07.03.2022 / 13:57

Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer

Name:	Heidelberg Pharma AG
Street:	Gregor-Mendel-Str. 22
Postal code:	68526
City:	Ladenburg Germany
Legal Entity Identifier (LEI):	391200E09XYBYITR1W32

2. Reason for notification

	Acquisition/disposal of shares with voting rights
X	Acquisition/disposal of instruments
	Change of breakdown of voting rights
	Other reason:

3. Details of person subject to the notification obligationNatural person (first name, surname): Kaijun Hu

Date of birth: 22 Sep 1962

4. Names of shareholder(s)

holding directly 3% or more voting rights, if different from 3.

5. Date on which threshold was crossed or reached:27 Feb 2022

6. Total positions

	% of voting rights attached to shares (total of 7.a.)	% of voting rights through instruments (total of 7.b.1 + 7.b.2)	Total of both in % (7.a. + 7.b.)	Total number of voting rights pursuant to Sec. 41 WpHG
New	0.00 %	20.85 %	20.85 %	34175809
Previous notification	n/a %	n/a %	n/a %	/

7. Details on total positions

a. Voting rights attached to shares (Sec. 33, 34 WpHG)

ISIN	Absolute		In %
	Direct (Sec. 33 WpHG)	Indirect (Sec. 34 WpHG)	Direct (Sec. 33 WpHG)	Indirect (Sec. 34 WpHG)
	0	0	0.00 %	0.00 %
Total	0		0.00 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Voting rights absolute	Voting rights in %
			0	0.00 %
		Total	0	0.00 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Cash or physical settlement	Voting rights absolute	Voting rights in %
Conditional Call Option	n/a	n/a	Physical	7124001	20.85 %
			Total	7124001	20.85 %

8. Information in relation to the person subject to the notification obligation

	Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X	Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name	% of voting rights (if at least 3% or more)	% of voting rights through instruments (if at least 5% or more)	Total of both (if at least 5% or more)
Kaijun Hu	%	%	%
Beijing Yuan Da Hua Chuang Investment Limited	%	%	%
China Grand Enterprises, Inc.	%	%	%
Huadong Medicine Co., Ltd.	%	%	%
Huadong Medicine Investment Holding (Hongkong) Limited	%	20.85 %	20.85 %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG

(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:

Holding total positions after general meeting (6.) after annual general meeting:

Proportion of voting rights	Proportion of instruments	Total of both
%	%	%

10. Other explanatory remarks:

The instrument is a contractual arrangement pursuant to which Huadong Medicine Investment Holding (Hongkong) Limited has, subject to the fulfilment of certain conditions that are not solely in the control of Huadong Medicine Investment Holding (Hongkong) Limited, the right to request the conclusion of a share purchase agreement for up to 7,124,001 shares in Heidelberg Pharma AG.

Date

03 March 2022

---

07.03.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de

---

Language:	English
Company:	Heidelberg Pharma AG
	Gregor-Mendel-Str. 22
	68526 Ladenburg
	Germany
Internet:	www.heidelberg-pharma.com

End of News	DGAP News Service